NeoDynamics AB NeoDynamics AB (publ) is a Swedish medical technology company dedicated to improving diagnostics and treatment of cancer. The company has created an innovative precision biopsy system called NeoNavia. This biopsy system builds on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is being evaluated for breast cancer diagnosis in leading clinics in Great Britain, Germany, and Sweden. More than 600 patients have already been tissue sampled by the biopsy system which has now been launched on the market, including in the USA.
Anna Eriksrud, CEO of NeoDynamics
We at NeoDynamics want to contribute to better diagnostic methods for the millions of women in the world who suffer from breast cancer each year to increase their chances of survival.